HAEMATOLOGICAL MALIGNANCY
Clinical trials for HAEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HAEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HAEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could existing melanoma drugs work for other rare cancers? new trial aims to find out.
Disease control Not yet recruitingThis trial tests two approved drugs, dabrafenib and trametinib, in people with rare cancers that have a BRAF V600 mutation. The drugs are already used for melanoma and lung cancer. About 30 adults, children, and teens will take part. The goal is to see if the drugs shrink tumors …
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New study aims to fix unequal referrals for blood cancer patients
Knowledge-focused Not yet recruitingThis study surveys doctors and nurses to understand how they decide to refer patients with chronic lymphocytic leukemia (CLL) to specialists. Researchers will look for differences in referral patterns across the West Midlands region of the UK. The goal is to identify inequalities…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Knowledge-focused
Last updated May 04, 2026 16:25 UTC